Login / Signup

Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis.

Victoria BaryshnikovaYuriy TurchenkoKsenia TuchynskayaIlmira BelyaletdinovaAlexander ButenkoAlena V DereventsovaGeorgy IgnatievIvan S KholodilovVictor LarichevEkaterina LyapeykovaAnastasiya RogovaArmen ShakaryanAnna ShishovaAnatoly GmylGalina Karganova
Published in: Diagnostics (Basel, Switzerland) (2023)
The tick-borne encephalitis virus (TBEV) is one of the most common members of the Orthoflavivirus genus, which comprises the causative agents of severe diseases in humans and animals. Due to the expanding areas of orthoflavivirus infection, its differential diagnosis is highly demanded. Commercial test kits based on inactivated TBEV may not provide reliable differentiation between flaviviruses because of serological crossover in this genus. Application of recombinant domains (sE and dIII) of the TBEV Sukhar-strain protein E as antigens in an ELISA test system allowed us to identify a wide range of antibodies specific to different TBEV strains. We tested 53 sera from human patients with confirmed TBE diagnosis (the efficacy of our test system based on sE protein was 98%) and 56 sera from patients with other orthoflavivirus infections in which no positive ones were detected using our ELISA test system, thus being indicative of its 100% specificity. We also tested mouse and rabbit sera containing antibodies specific to 17 TBEV strains belonging to different subtypes; this assay exhibited high efficacy and differentiation ability in detecting antibodies against TBEV from other orthoflaviviruses such as Omsk hemorrhagic fever, Powassan, yellow fever, dengue, West Nile, Zika, and Japanese encephalitis viruses.
Keyphrases
  • zika virus
  • endothelial cells
  • randomized controlled trial
  • clinical trial
  • binding protein
  • dendritic cells
  • early onset
  • aedes aegypti
  • immune response
  • monoclonal antibody
  • small molecule
  • double blind